People with diabetes who were taking GLP-1 receptor agonist drugs had significantly lower rates of hospital readmission, wound reopening and hematoma after surgery, according to new study.
Weill Cornell Medicine has received a five-year, $2.3 million grant from the Centers for Disease Control and Prevention to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.
The hormone estrogen regulates binge drinking in females, causing them to “pregame” – consume large quantities of alcohol in the first 30 minutes after it’s offered, according to a preclinical study led by scientists at Weill Cornell Medicine.
Immune cells in the brain can partially break down large amyloid plaques characteristic of Alzheimer’s disease by latching on to them, forming a sort of external stomach and releasing digestive enzymes into the space, according to a preclinical study by Weill Cornell Medicine investigators.
A cell protein previously believed only to provide a scaffolding for DNA has also been shown to directly influence DNA transcription into RNA – the first step of the process by which an organism’s genetic code expresses itself.
Neuroscientist Gary Gibson, Ph.D. ’73, keeps a framed picture of a cell derived from the skin cells of a person with Alzheimer’s disease on his office wall.
The image is a memento of Gibson’s breakthrough…
A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease.
Two friends who bonded over shared concerns over their bone health have formulated a bioavailable calcium chew using milk protein from Finger Lakes dairy farms.
Reinforcement Learning, an artificial intelligence approach, has the potential to guide physicians in designing sequential treatment strategies for better patient outcomes but requires significant improvements before it can be applied in clinical settings.
